RTA 408 Ameliorates Diabetic Cardiomyopathy by Activating Nrf2 to Regulate Mitochondrial Fission and Fusion and Inhibiting NF-κB-mediated Inflammation.

Jinjin Hao,Jiedong Zhou,Songqing Hu,Peipei Zhang,Haowei Wu,Juntao Yang,Bingjie Zhao,Hanxuan Liu,Hui Lin,Jufang Chi,Dajun Lou
DOI: https://doi.org/10.1152/ajpcell.00467.2023
2023-01-01
AJP Cell Physiology
Abstract:We demonstrated first that the nuclear factor erythroid 2-related factor 2 (Nrf2) activator RTA 408 has a protective effect against diabetic cardiomyopathy. We found that RTA 408 could stimulate the nuclear entry of Nrf2 protein, regulate the mitochondrial fission-fusion balance, and redistribute p65, which significantly alleviated the oxidative stress level in cardiomyocytes, thereby reducing apoptosis and inflammation, and protecting the systolic and diastolic functions of the heart.
What problem does this paper attempt to address?